This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Marlene Fredenwall: Innovator in Pharmaceutical Chemistry
Introduction
Marlene Fredenwall is a notable inventor based in Molndal, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications.
Latest Patents
Marlene holds a patent for a compound described as (3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone. This patent discloses azetidinyl compounds that are utilized in pharmaceutical compositions. These compounds are particularly relevant for the treatment or prophylaxis of diseases related to melanin-concentrating hormone.
Career Highlights
Marlene is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her work focuses on the development of innovative therapeutic solutions that address critical health challenges.
Collaborations
Marlene has collaborated with esteemed colleagues, including Susanne Doris Margit Bökman-Winiwarter and Carl Anders Hogner. These collaborations have further enhanced her research and development efforts in the pharmaceutical sector.
Conclusion
Marlene Fredenwall's contributions to pharmaceutical chemistry exemplify her commitment to innovation and improving healthcare outcomes. Her work continues to impact the field positively, showcasing the importance of research and development in medicine.